4P-020

N/A

Report date: 2024/03/08 17:25:10

First In Class

Base Information

Drug Name4P-020

Drug Alias Name4P-020

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-3 adrenergic receptor agonists

TargetsBeta-3 adrenergic receptor

Therapy Area/IndicationsGeographic AtrophyStargardt Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies4P-Pharma Ltd

China Registration ClassN/A

Active Companies4P-Pharma Ltd

Inactive CompaniesN/A

Active IndicationsGeographic AtrophyStargardt Disease

Inactive IndicationsN/A

ATC CodeN/A